INTERNATIONAL CONGRESS OF
CancerGenetics
برنامه سخنرانی ها
Epigenetics and Cancer Panel Panel
2026/10/23
08:00-08:15 | Welcome Message by the Chair of the Epigenetics and Cancer Panel
Dr. Elahe Motevaseli
|
Chairman
Position of Speaker
Department of Molecular Medicine, School of Advanced Technologies in Medicine,Tehran University of Medical Sciences, Tehran, Iran.
Contact
Email: ElaheMotevaseli [at] icgcongress [dot] com
08:15-08:45 | Reversible Epigenetics: Therapeutic Opportunity or Hidden Obstacle?
Dr. Reza Shirkoohi
|
Speaker
Position of Speaker
Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran Iran.
Contact
Email: RezaShirkoohi [at] icgcongress [dot] com
08:45-09:15 | Zebrafish Avatars: A Precision Oncology Platform for Personalized Medicine & Discovery of Innate Immune Mechanisms
Dr. Rita Fior
|
Speaker
Position of Speaker
Fior Lab – Cancer Development and Innate Immune EvasionChampalimaud Centre for the Unknown, Champalimaud Foundation
Contact
Email: RitaFior [at] icgcongress [dot] com
09:15-09:45 | Remember & Forget: Mechanisms of Epigenetic Transcriptional Memory
Dr. Pawel Mikalski
|
Speaker
Position of Speaker
Laboratory of Immunological Epigenetics
Contact
Email: PawelMikalski [at] icgcongress [dot] com
09:45-10:15 | Three-Dimensional Genome Architecture in Cancer: From Disrupted Chromatin Topology to Oncogenesis
Dr. Gholamreza Tavoosi Dana
|
Speaker
Position of Speaker
Department of Molecular Medicine, School of Advanced Technologies in Medicine,Tehran University of Medical Sciences, Tehran, Iran.
Contact
Email: GholamrezaTavoosiDana [at] icgcongress [dot] com
10:15-10:45 | Non-Coding RNA Signatures in Cancer: From Diagnostic Biomarkers to Therapeutic Targets
Dr. Soodeh Ghafourifard
|
Speaker
Position of Speaker
Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Contact
Email: SoodehGhafourifard [at] icgcongress [dot] com
10:45-11:15 | ALU-based cell-free DNA and serum onco-piRNA in colorectal cancer patients management
Dr. Mohammad Taghizadeh-teymorloei
|
Speaker
Position of Speaker
Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
Contact
Email: MohammadTaghizadeh-teymorloei [at] icgcongress [dot] com
Carcinogenic Viruses Panel
2026/10/23
11:45-12:00 | Welcome Message by the Chair of the Carcinogenic Viruses Panel
Dr. Rahim Soleimani jelodar
|
Chairman
Position of Speaker
Gastroenterology and Liver Diseases Research Center; Shahid Beheshti University of Medical Sciences
Contact
Email: RahimSoleimanijelodar [at] icgcongress [dot] com
12:00-12:30 | Mechanisms of HPV Carcinogenesis
Dr. Maryam Vaezjalali
|
Speaker
Position of Speaker
Department of Microbiology, School of Medicine; Shahid Beheshti University of Medical Sciences
Contact
Email: MaryamVaezjalali [at] icgcongress [dot] com
12:30-13:00 | The Awakened Genome: Role of HERVs in HPV-Associated Cancers
Dr. Rahim Soleimani jelodar
|
Speaker
Position of Speaker
Gastroenterology and Liver Diseases Research Center; Shahid Beheshti University of Medical Sciences
Contact
Email: RahimSoleimanijelodar [at] icgcongress [dot] com
13:00-13:30 | Immune Responses to HPV and New HPV Vaccines
Dr. Fatemeh Ebrahimi
|
Speaker
Position of Speaker
Department of Virology, School of Public Health; Tehran University of Medical Sciences.
Contact
Email: FatemehEbrahimi [at] icgcongress [dot] com
13:30-14:00 | Clinical Management of HPV-Associated Cancers
Dr. Setare Akhavan
|
Speaker
Position of Speaker
Department of Gynecology Oncology, Imam Khomeini Hospital Complex, Valiasr Hospital, Tehran University of Medical Sciences
Contact
Email: SetareAkhavan [at] icgcongress [dot] com
The role of the microbiome in cancer Panel
2026/10/24
8:00-8:15 | Welcome Message by the Chair of the role of the microbiome in cancer Panel
Dr. Masoud Mardani
|
Chairman
Position of Speaker
Shahid Beheshti University of Medical Sciences
Contact
Email: MasoudMardani [at] icgcongress [dot] com
8:15-8:45 | Improve knowledge on role of microbiota in cancer
Dr. Masoud Mardani
|
Speaker
Position of Speaker
Shahid Beheshti University of Medical Sciences
Contact
Email: MasoudMardani [at] icgcongress [dot] com
08:45-09:15 | The role of microbiome in gastrointestinal cancers and chemotherapy response
Dr. Mona Akbari
|
Speaker
Position of Speaker
MD | Pathologist | Fellowship in Gastrointestinal and Liver Pathology Mona Pathobiology Laboratory, Tehran, Iran
Contact
Email: MonaAkbari [at] icgcongress [dot] com
09:15-09:45 | Probiotic-Based Genetic Analysis in Irritable Bowel Syndrome (IBS) and Colorectal Cancer
Dr. Seyed Mohammad Hossein Ghaderian
|
Speaker
Position of Speaker
Shahid Beheshti University of Medical Sciences
Contact
Email: SeyedMohammadHosseinGhaderian [at] icgcongress [dot] com
9:45-10:15 | Role of microbiota in HEMATOLOGY & GVHD
Dr. Sohrab Aghabeigi
|
Speaker
Position of Speaker
Assistant professor of hematology & medical oncology Tehran university of medical sciences Shariati hospital
Contact
Email: SohrabAghabeigi [at] icgcongress [dot] com
10:15-10:45 | Mycology and cancer
Dr. Azadeh Bandegani
|
Speaker
Position of Speaker
Shahid Beheshti University of Medical Sciences
Contact
Email: AzadehBandegani [at] icgcongress [dot] com
Polymorphisms and Metabolic Interactions in Cancer Panel
2026/10/24
11:45-12:00 | Welcome Message by the Chair of Polymorphisms and Metabolic Interactions in Cancer Panel
Dr. Majid Mesgartehrani
|
Chairman
Position of Speaker
Contact
Email: MajidMesgartehrani [at] icgcongress [dot] com
12:00-12:30 | Pharmacogenomics in Cancer Care From Genotype to Safer, Smarter Treatment Decisions
Dr. Sara Cheraghi
|
Speaker
Position of Speaker
Nutrition and Health Research Center, Nasim Institute, Tehran, Iran
Contact
Email: SaraCheraghi [at] icgcongress [dot] com
12:30-13:00 | Cancer-Associated Genetic Polymorphisms: Recent Advances, Common Variants, and Their Significance in Whole-Exome Sequencing
Dr. Maryam Esmaeilzadeh Aghjeh
|
Speaker
Position of Speaker
Division of Medical Genetics, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Contact
Email: MaryamEsmaeilzadehAghjeh [at] icgcongress [dot] com
13:00-13:30 | Polymorphism at the Crossroads of Kingdoms; Shared Genetic Variation in Plant and Human Disease Responses
Dr. Seyedeh Zohreh Saderi
|
Speaker
Position of Speaker
PhD in Plant Physiology Nasim Research Institute
Contact
Email: SeyedehZohrehSaderi [at] icgcongress [dot] com
13:30-14:00 | Polyploidy in Cancer: From Genomic Instability to Therapeutic Targeting
Dr. Ali Zekri
|
Speaker
Position of Speaker
Dept. of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Contact
Email: AliZekri [at] icgcongress [dot] com
14:00-14:30 | Variant Allele Frequency (VAF) in targeted tumour molecular profiling Is this what it is???
Dr. Gholamreza Rafiei
|
Speaker
Position of Speaker
Genome medical genetics laboratory director
Contact
Email: GholamrezaRafiei [at] icgcongress [dot] com
14:30-15:30 | Central Nervous System Tumours: Eultra fast diagnosis, Neoclassification and Personalized medicine.
Dr. Ali Goudarzi
|
Speaker
Position of Speaker
Contact
Email: AliGoudarzi [at] icgcongress [dot] com
Bioinformatics in Cancer Panel Panel
2026/10/25
08:00-8:15 | Welcome Message by the Chair of Bioinformatics in Cancer Panel
Dr. Mohammad Amin Tabatabaeifar
|
Chairman
Position of Speaker
Contact
Email: MohammadAminTabatabaeifar [at] icgcongress [dot] com
8:15-8:45 | The rolls of Bioinformatics in the Precision Medicine of Cancer
Dr. Mohammad Amin Tabatabaeifar
|
Speaker
Position of Speaker
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Contact
Email: MohammadAminTabatabaeifar [at] icgcongress [dot] com
8:45-9:15 | The Importance of Developing and Deploying Local Pipelines for Genomic Data Analysis
Dr. Mohammadreza Sehhati
|
Speaker
Position of Speaker
Department of Bioinformatics, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciencies, Isfahan, Iran
Contact
Email: MohammadrezaSehhati [at] icgcongress [dot] com
9:15-9:45 | Genetic Guidelines for Breast Cancer (Diagnosis, Hereditary risk assessment & Variant Interpretation)
Dr. AKram Sarmadi
|
Speaker
Position of Speaker
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Contact
Email: AKramSarmadi [at] icgcongress [dot] com
9:45-10:15 | Tumor Sequencing in Clinical Decision Making
Dr. Razieh Fatehi
|
Speaker
Position of Speaker
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Contact
Email: RaziehFatehi [at] icgcongress [dot] com
Gene Editing in Cancer Panel
2026/10/25
11:45-12:00 | Welcome Message by the Chair of Gene Editing in Cancer Panel
Prof. Gholam Ali Kardar
|
Chairman
Position of Speaker
Contact
Email: Prof.GholamAliKardar [at] icgcongress [dot] com
12:00-12:30 | Cancer therapy by genome editing
Prof. Gholam Ali Kardar
|
Speaker
Position of Speaker
Contact
Email: Prof.GholamAliKardar [at] icgcongress [dot] com
12:30-13:00 | RNA-Triggered CRISPR-Cas12a2 for Selective Cancer Cell Killing
Dr. Salehi poor
|
Speaker
Position of Speaker
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences
Contact
Email: Salehipoor [at] icgcongress [dot] com
13:00-13:30 | Expression of attempts in CAR T cell therapy in Iran
Dr. Fatemeh Rahbarizadeh
|
Speaker
Position of Speaker
Tehran, Tarbiat Modares University, Faculty of Medical Sciences, Department of Medical Biotechnology.
Contact
Email: FatemehRahbarizadeh [at] icgcongress [dot] com
Oral presentations
A Practical Framework for Modeling and Engineering the Bone Marrow Tumor Microenvironment, Focusing on Key Parameters and Therapeutic Applications
Panel: Carcinogenic Viruses
A review context on the current concepts of gene therapy
Panel: Regenerative Medicine in Cancer Treatment Panel
A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer
Panel: Drug Resistance and Novel Therapeutic Targets
Analytical Review of Novel Gene Therapy and Gene Editing (CRISPR) Approaches in Molecular Targeting of Cancer: Challenges and Future Horizons in Medical Biotechnology”
Panel: Gene Editing in Cancer
Antibacterial and Antibiofilm Activity of Lactobacillus-Derived Cell-Free Supernatants Against Multidrug-Resistant Pseudomonas aeruginosa: Synergistic Effects With Antibiotics and Suppression of Biofilm-Associated Genes
Panel: Drug Resistance and Novel Therapeutic Targets
Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells: molecular docking and in vitro studies
Panel: Drug Resistance and Novel Therapeutic Targets
Artificial Intelligence and Machine Learning–Driven Interpretation of Non-Coding and Structural Variants in Cancer Genomics
Panel: AI and Digital Pathology in Precision Oncology
Beyond BRCA1/2: Germline Pathogenic Variants in Fanconi Anemia Pathway Genes Identified Through Whole-Exome Reanalysis in Early-Onset Breast Cancer
Panel: Carcinogenic Viruses
Bidirectional Dysregulation of Unprocessed Pseudogene Expression in Testicular Germ Cell Tumors
Panel: Bioinformatics in Cancer Panel
Circular RNAs in Hepatocellular Carcinoma: Molecular Mechanisms, Tumor Microenvironment, Therapeutic Resistance, and Clinical Potential
Panel: Regenerative Medicine in Cancer Treatment Panel
Cross-Cohort Transcriptomic Meta-Analysis Identifies GAB1 as a Reproducible Signal of Platinum Resistance in High-Grade Serous Ovarian Cancer
Panel: Drug Resistance and Novel Therapeutic Targets
Effects of Curcumin Supplementation on Inflammatory, Oxidative Stress, and Anticancer Markers in Patients with Chronic Myeloid Leukemia: A Systematic Review
Panel: Carcinogenic Viruses
Electro-Ionic Tumor Microenvironment as a Design Cue for Engineering Smart Drug Delivery Systems
Panel: Carcinogenic Viruses
Epstein–Barr Virus-Encoded MicroRNAs in Gastric Cancer: Linking Viral Epigenetic Regulation to Tumor Progression and Clinical Outcome
Panel: Carcinogenic Viruses
Eugenol as a Novel Antibiotic Adjuvant Against Carbapenem-Resistant Acinetobacter baumannii: Synergistic Activity With Carbapenems and Downregulation of OXA-51
Panel: Drug Resistance and Novel Therapeutic Targets
Identification of HRH1-Associated Candidate Genes Potentially Involved in 5-Fluorouracil Resistance in Colon Cancer: A Bioinformatic Analysis
Panel: Bioinformatics in Cancer
Identification of Survival-Related Genes in Acute Myeloid Leukemia: A Study Based on TCGA Data Analysis
Panel: Bioinformatics in Cancer
Integrated Multi-Cohort Transcriptomic Analysis Identifies BST2 as a Candidate Immune-Associated Biomarker in Non-Small cell lung cancer
Panel: Tumor Immunology and Cancer Immunotherapy
Integrated Multi-Cohort Transcriptomic Analysis Identifies BST2 as a Candidate Immune-Associated Biomarker in Triple-Negative Breast Cancer
Panel: Bioinformatics in Cancer Panel
Lactate-Mediated Mechanisms of Cancer Therapy Resistance
Panel: Regenerative Medicine in Cancer Treatment Panel
Mesenchymal Stem Cell-Derived Exosomal Non-Coding RNAs as Suppressors of Hepatocellular Carcinoma Progression
Panel: Regenerative Medicine in Cancer Treatment Panel
Metabolic–Epigenetic Crosstalk in Human Disease: How Metabolites Control Gene Expression and Cellular Function
Panel: Personalized medicine in cancer
Molecular and histopathology study on the effects of Cisplatin and Naringenin in mice with induced breast cancer
Panel: Personalized medicine in cancer
Network-Based Identification of Paclitaxel-Associated Targets and Regulatory Mechanisms in HER2-Positive Breast Cancer
Panel: Bioinformatics in Cancer
Nuclear–Mitochondrial Genome Crosstalk in Cancer: Linking Metabolic Reprogramming to Precision Oncology
Panel: Polymorphisms and Metabolic Interactions in Cancer
Pancreatic Cancer and DNA Damage Repair Deficiency: Mechanisms, Biomarkers, and Therapeutic Implications
Panel: Personalized medicine in cancer
Processed Pseudogene Dysregulation in Testicular Germ Cell Tumors Reveals High-Contrast Molecular Candidates
Panel: Bioinformatics in Cancer Panel
Revisiting the Warburg Effect: Metabolic Plasticity, Lactate Signaling, and Therapeutic Opportunities in Cancer
Panel: Polymorphisms and Metabolic Interactions in Cancer
Role of Antihistamines in Modulating Drug Resistance in Colorectal Cancer
Panel: Drug Resistance and Novel Therapeutic Targets
Role of CRISPR/Cas9 Gene Editing in Targeting CXCR4, CD133 and EpCAM to Inhibit Cell Adhesion and Metastasis in Colorectal Cancer
Panel: Regenerative Medicine in Cancer Treatment Panel
Role of PDEV in Cancer Immunotherapy
Panel: Tumor Immunology and Cancer Immunotherapy
Roles of Sirtuin-1 in Lung Cancer: From Tumor Progression to Targeted Therapy
Panel: Drug Resistance and Novel Therapeutic Targets
Single-Cell and Spatial Multi-Omics in Cancer: Deciphering Tumor Heterogeneity and Advancing Precision Oncology
Panel: Single-Cell & Spatial Omics in Cancer
Splicing impact assessment of canonical splice-site LZTR1 variants of uncertain significance highlights the gap between predicted splice disruption and clinical variant interpretation
Panel: Bioinformatics in Cancer Panel
Studying the effects of Cisplatin and Artemisinin on the expression of apoptosis-related genes in mice
Panel: Personalized medicine in cancer
The Mitochondrial Transfer Paradox: A Comparative Transcriptomic and Connectivity Map Profiling of Divergent Fates in Tumor and Immune Cells
Panel: Bioinformatics in Cancer Panel
The SDF-1 3'A Genetic Variation Is Correlated with Elevated Intra-tumor Tissue and Circulating Concentration of CXCL12 in Glial Tumors
Panel: Polymorphisms and Metabolic Interactions in Cancer
Torque Teno Virus Coinfection with High-Risk Human Papillomavirus in Cervical Cancer-Related Samples:
Panel: Carcinogenic Viruses
Tumor-Suppressor Checkpoints in Partial Reprogramming: Balancing Epigenetic Rejuvenation, Lineage Fidelity, and Oncogenic Risk
Panel: Epigenetics and Cancer Panel
Poster presentations
A Practical Framework for Modeling and Engineering the Bone Marrow Tumor Microenvironment, Focusing on Key Parameters and Therapeutic Applications
Panel: Carcinogenic Viruses
A Review of Gene therapy in cancer
Panel: Bioinformatics in Cancer Panel
Adenoviral Vector-Mediated Monoclonal Antibody Gene Delivery in Cancer Immunotherapy: Opportunities and Challenges
Panel: Personalized medicine in cancer
An update on application of niosomes for delivering miRNA, siRNA, and anticancer drugs: A review
Panel: Epigenetics and Cancer Panel
Antibacterial and Antibiofilm Activity of Lactobacillus-Derived Cell-Free Supernatants Against Multidrug-Resistant Pseudomonas aeruginosa: Synergistic Effects With Antibiotics and Suppression of Biofilm-Associated Genes
Panel: Drug Resistance and Novel Therapeutic Targets
Application of Artificial Intelligence in Cancer Radiology and Prediction of Tumor Surgical Outcomes: A Systematic Review of Radiomic Models and Multimodal Approaches
Panel: Regenerative Medicine in Cancer Treatment Panel
Application of Artificial Intelligence in the Diagnosis of Lung Cancer from Pathology Slides: A Systematic Review
Panel: Personalized medicine in cancer
Artificial Intelligence and Bioinformatics in Cancer: From Multi-Omics Integration to Precision Immunotherapy
Panel: Bioinformatics in Cancer Panel
Artificial Intelligence and Machine Learning–Driven Interpretation of Non-Coding and Structural Variants in Cancer Genomics
Panel: AI and Digital Pathology in Precision Oncology
Artificial Intelligence Strategies in Clinical Pathology and Radiology for Cancer Diagnosis: A Systematic Review
Panel: Personalized medicine in cancer
Association Between Metabolic Syndrome and Colorectal Cancer Risk and Mortality: Insights from Epidemiological, Genetic, and Molecular Evidence
Panel: Polymorphisms and Metabolic Interactions in Cancer
Association between rs6850524 Polymorphism in the CLOCK gene and susceptibility to breast cancer in Women from East Azerbaijan Province, Iran
Panel: Polymorphisms and Metabolic Interactions in Cancer
Beyond BRCA1/2: Germline Pathogenic Variants in Fanconi Anemia Pathway Genes Identified Through Whole-Exome Reanalysis in Early-Onset Breast Cancer
Panel: Carcinogenic Viruses
Bidirectional Dysregulation of Unprocessed Pseudogene Expression in Testicular Germ Cell Tumors
Panel: Bioinformatics in Cancer Panel
Bioinformatics analysis of potential core genes for Esophageal squamous cell carcinoma
Panel: Bioinformatics in Cancer Panel
Breast Cancer and the Microbiota: Insights into Disease Development and Progression
Panel: The role of the microbiome in cancer
Cationic Liposome-Encapsulated Adenoviruses: Overcoming CAR-Dependent Resistance & Systemic Antitumor Immunity
Panel: Personalized medicine in cancer
cfDNA Methylation in Liquid Biopsy: Current Perspectives and Future Directions for Early Cancer Detection
Panel: Epigenetics and Cancer Panel
Challenges and Emerging Strategies of CAR-T Cell Therapy in Solid Tumors: A Narrative Review
Panel: Tumor Immunology and Cancer Immunotherapy
Circular RNAs in Hepatocellular Carcinoma: Molecular Mechanisms, Tumor Microenvironment, Therapeutic Resistance, and Clinical Potential
Panel: Regenerative Medicine in Cancer Treatment Panel
Circulating piRNAs in Colorectal Cancer: From Biomarker Discovery to Clinical Monitoring
Panel: Epigenetics and Cancer Panel
Combined application of nanotechnology and artificial intelligence in cancer radiology: A systematic review
Panel: Personalized medicine in cancer
Comparative Transcriptomic and Network-Based Analysis of the Tumor Core and Peritumoral Margin in Glioma
Panel: Bioinformatics in Cancer
CORRECTED! Microbial Genotoxicity, Epigenetic Reprogramming, Host Genotype, and Oncogenic Signaling in Cancer: A Mechanistic Review of Host-Microbiome Crosstalk
Panel: The role of the microbiome in cancer
CRISPR-Engineered Akkermansia muciniphila Synergizes with Intratumoral Microbiome Remodeling to Overcome Immunotherapy Resistance in KRAS-Mutant Colorectal Cancer
Panel: Personalized medicine in cancer
Cross-Cohort Transcriptomic Meta-Analysis Identifies GAB1 as a Reproducible Signal of Platinum Resistance in High-Grade Serous Ovarian Cancer
Panel: Drug Resistance and Novel Therapeutic Targets
Deciphering Tumor Molecular Heterogeneity in the Era of Precision Medicine.
Panel: Single-Cell & Spatial Omics in Cancer
Decoupling Cellular Rejuvenation from Oncogenic Plasticity: A Single-Cell and Multi-Omic Framework for Identity-Preserving Partial Reprogramming
Panel: Multi-omics and Systems Oncology
Development and Immunological Application of Bispecific Antibodies in the Treatment of Gastric Cancer
Panel: Tumor Immunology and Cancer Immunotherapy
Differential expression of LncRNA ITPK1-AS1 gene expression in gastric cancer
Panel: Bioinformatics in Cancer Panel
Drug Use Evaluation (DUE) of 5- Fluorouracil and Oxaliplatin and their’s related adverse drug reactions in cancer patient at Boali hospital
Panel: Regenerative Medicine in Cancer Treatment Panel
Effects of Sialic Acid and Temozolomide on GFAP Gene Expression in the 1321N1 Glioma Cell Line
Panel: Polymorphisms and Metabolic Interactions in Cancer
Efficacy and Safety of Immune Checkpoint Inhibitors in MSI-High Colorectal Cancer
Panel: Regenerative Medicine in Cancer Treatment Panel
Electro-Ionic Tumor Microenvironment as a Design Cue for Engineering Smart Drug Delivery Systems
Panel: Carcinogenic Viruses
EMERGING MOLECULAR TARGETS AND MECHANISMS OF DRUG RESISTANCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: TOWARD PERSONALIZED OPHTHALMIC THERAPY
Panel: Drug Resistance and Novel Therapeutic Targets
Engineering Bacterial cellulose for Cancer Drug Delivery: From Controlled Release to Therapeutic Applications
Panel: Drug Resistance and Novel Therapeutic Targets
Epigenetic and Metabolic Networks Shaping CAR-T Cell Exhaustion and Memory
Panel: Epigenetics and Cancer Panel
Epigenetic Footprints of Cancer in Cell-Free DNA and Their Applications in Early Cancer Detection
Panel: Epigenetics and Cancer Panel
Eugenol as a Novel Antibiotic Adjuvant Against Carbapenem-Resistant Acinetobacter baumannii: Synergistic Activity With Carbapenems and Downregulation of OXA-51
Panel: Drug Resistance and Novel Therapeutic Targets
Evaluation of a Recombinant HPV Based Therapeutic Vaccine in a Murine Model of Cervical Cancer
Panel: Regenerative Medicine in Cancer Treatment Panel
Evaluation of circulating concentrations of CXCL1 (Gro-α), CXCL10 (IP-10) and CXCL12 (SDF-1) in ALL patients prior and post bone marrow transplantation
Panel: Regenerative Medicine in Cancer Treatment Panel
Evaluation of the Therapeutic Potential of a Bifidobacterium longum-Derived Postbiotic in Skin Cancer: Concurrent Assessment of Anticancer and Antioxidant Activities
Panel: The role of the microbiome in cancer
Extrachromosomal DNA (ecDNA)-Associated Transcription–Replication Conflicts in Cancer: Mechanisms, Synthetic Lethal Vulnerabilities, and Emerging Personalized Therapeutic Strategies
Panel: Personalized medicine in cancer
Extrachromosomal DNA Heterogeneity in Dedifferentiated Liposarcoma: Linking Therapeutic Adaptation and Tumor Immune Evasion: A Narrative Review
Panel: Personalized medicine in cancer
From Clonal Evolution to Relapse: Genomic and Epigenetic Drivers of Treatment Resistance in Pediatric B-Cell Acute Lymphoblastic Leukemia — A Systematic Review
Panel: Bioinformatics in Cancer Panel
From L-Asparaginase Engineering to Precision Medicine: The Role of ASNS in Leukemic Cell Sensitivity
Panel: Epigenetics and Cancer Panel
From Viral Detection to Oncogenic Evidence: A Targeted Scoping Review of Thresholds, Contamination Control, Validation, and Causality Assessment in Human Tumor Sequencing Studies
Panel: Carcinogenic Viruses
Fusobacterium nucleatum in Colorectal Cancer: Molecular Crosstalk Between Microbial Virulence and Host Oncogenic Signaling
Panel: The role of the microbiome in cancer
Genomic Alterations and Their Role in the Management of Uterine Carcinosarcoma: Focus on TP53 and Biomarker-Guided Therapy
Panel: Gene Editing in Cancer
Genomic Alterations in Cancer: Implications for Precision Diagnosis and Targeted Therapy
Panel: Bioinformatics in Cancer Panel
Genomic Biomarkers in Precision Therapy for Ovarian Cancer: Current Advances, Clinical Challenges, and Future Perspectives
Panel: Personalized medicine in cancer
Gut Microbiome and Colorectal Cancer: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities
Panel: The role of the microbiome in cancer
Gut Microbiome–Neural Crosstalk in Cancer: Emerging Implications for Perineural Invasion and Metastatic Progression
Panel: The role of the microbiome in cancer
How Germline DNA-Repair Variants May Influence the Intratumoral Microbiome in Breast Cancer: An Emerging Mechanistic Hypothesis
Panel: The role of the microbiome in cancer
Human Milk miRNAs and Cancer: From Early-Life Molecular Programming to Cancer Risk
Panel: Epigenetics and Cancer Panel
Identification of Candidate Drugs for Breast Cancer via Transcriptomic Signature Matching Using Connectivity Map
Panel: Multi-omics and Systems Oncology
Identification of Hub Genes Associated with Tamoxifen Treatment in Recurrent Breast Cancer: An Integrated Bioinformatics Analysis
Panel: Bioinformatics in Cancer
Immune Checkpoints Dysregulation in Precancerous Colorectal Polyps
Panel: Tumor Immunology and Cancer Immunotherapy
Immunotherapy for Cervical Cancer: Mechanistic Insights, Clinical Challenges, and Synergistic Combination Paradigms
Panel: Tumor Immunology and Cancer Immunotherapy
In Silico Transcriptomic Analysis of Radiation-Induced Bystander Effects in Human Fibroblasts: Uncovering Key Regulatory Networks and Ribosome Biogenesis
Panel: Bioinformatics in Cancer Panel
Inhibitory Study of Thyme and Garlic Extracts on Key Receptors in Inflammation and Cancer with a Bioinformatics Approach
Panel: Bioinformatics in Cancer
Integrated Multi-Cohort Transcriptomic Analysis Identifies BST2 as a Candidate Immune-Associated Biomarker in Non-Small cell lung cancer
Panel: Tumor Immunology and Cancer Immunotherapy
Integrated Multi-Cohort Transcriptomic Analysis Identifies BST2 as a Candidate Immune-Associated Biomarker in Triple-Negative Breast Cancer
Panel: Bioinformatics in Cancer Panel
Interferon-Related Hub Genes in Resistant Breast Cancer CAFs
Panel: Bioinformatics in Cancer
Interpreting Colibactin-Associated Mutational Signatures and pks⁺ Bacterial Detection in Colorectal Cancer: Temporal Discordance and Biomarker Limitations
Panel: The role of the microbiome in cancer
Introduction of AOX1 gene as an effective gene in tumorigenesis in thyroid papillary carcinoma
Panel: Bioinformatics in Cancer Panel
Investigating the Effects of miR-204-Enriched Mesenchymal Stem Cell-Derived Exosomes on TGF-β1-Induced EMT in 4T1 Breast Cancer Cells
Panel: Regenerative Medicine in Cancer Treatment Panel
Lack of Correlation Between the CCR5-D32 Mutation and Acute Myeloid Leukemia in Iranian Patients
Panel: Polymorphisms and Metabolic Interactions in Cancer
Lactate-Mediated Mechanisms of Cancer Therapy Resistance
Panel: Regenerative Medicine in Cancer Treatment Panel
Low-Allele-Fraction Pathogenic/Likely Pathogenic Calls in Diagnostic Whole-Exome Sequencing for Hereditary Breast Cancer: A Cautionary Case Series of Sanger Discordance
Panel: Bioinformatics in Cancer Panel
Mechanistic Insights into Long Non-coding RNA-Mediated Gene Regulation Across Human Diseases
Panel: Epigenetics and Cancer Panel
Mesenchymal stem cell derived exosomes as a potential carrier of non-coding RNA in cancer therapy
Panel: Personalized medicine in cancer
Mesenchymal Stem Cell-Derived Exosomal Non-Coding RNAs as Suppressors of Hepatocellular Carcinoma Progression
Panel: Regenerative Medicine in Cancer Treatment Panel
Metabolic–Epigenetic Crosstalk in Human Disease: How Metabolites Control Gene Expression and Cellular Function
Panel: Personalized medicine in cancer
miRNA-Mediated Regulation of the NRF2/KEAP1 Pathway in Glioblastoma
Panel: Epigenetics and Cancer Panel
Mitomycin and zinc oxide nanoparticle effect on p53 and endothelial growth factor VEGF genes expression in MCF-7 Breast cancer cell line
Panel: Bioinformatics in Cancer Panel
Molecular and histopathology study on the effects of Cisplatin and Naringenin in mice with induced breast cancer
Panel: Personalized medicine in cancer
Multi-Center Platform for Cancer Detection from Histopathology Images Using Federated Learning
Panel: Personalized medicine in cancer
Natural Seed Informed and Structure Aware Computational Design of Artificial miRNA Seed Regions Targeting the KRAS 3′UTR
Panel: Bioinformatics in Cancer Panel
Network-Based Identification of Paclitaxel-Associated Targets and Regulatory Mechanisms in HER2-Positive Breast Cancer
Panel: Bioinformatics in Cancer
Neuro-Cancer Crosstalk in the Tumor Immune Microenvironment: Molecular Mechanisms of Immune Evasion and Tumor-Promoting Inflammation
Panel: Tumor Immunology and Cancer Immunotherapy
Novel In-Vitro Evaluation of Synergistic Cytotoxicity of Thyme and Garlic Extract on CT26 Colon Cancer Cells
Panel: Personalized medicine in cancer
Nuclear–Mitochondrial Genome Crosstalk in Cancer: Linking Metabolic Reprogramming to Precision Oncology
Panel: Polymorphisms and Metabolic Interactions in Cancer
Optimizing Tumor-Stromal Exosome Dose for Enhanced Proliferation in MDA-MB-231 Breast Cancer Cells
Panel: Epigenetics and Cancer Panel
Pancreatic Cancer and DNA Damage Repair Deficiency: Mechanisms, Biomarkers, and Therapeutic Implications
Panel: Personalized medicine in cancer
Patient-Derived Thyroid Cancer Organoids for Precision Medicine: Preclinical Applications and Emerging Clinical Potential
Panel: Personalized medicine in cancer
Plant-Derived Berberine and Artesunate as Emerging Therapeutic Candidates Against Human Herpesvirus 8-Driven Kaposi Sarcoma: Molecular Mechanisms and Translational Perspectives
Panel: Carcinogenic Viruses
Precision Genome Editing in Oncology through Base and Prime Editing: Molecular Foundations, Genomic Fidelity, and Therapeutic Prospects
Panel: Gene Editing in Cancer
Precision Medicine in Oncology: Molecular Biomarkers and Genomic Strategies for Personalized Cancer Therapy
Panel: Personalized medicine in cancer
Preliminary Assessment of the Effects of Chicory-Derived Inulin on the Viability of Human Renal Carcinoma ACHN Cells
Panel: Carcinogenic Viruses
Processed Pseudogene Dysregulation in Testicular Germ Cell Tumors Reveals High-Contrast Molecular Candidates
Panel: Bioinformatics in Cancer Panel
Proteogenomic Divergence Between mRNA Abundance and Protein Output in Cancer: Implications for Kinase-Centric Pathway Modeling
Panel: Multi-omics and Systems Oncology
Recombinant oncolytic adenoviruses encoding PD-L1 inhibitors: a novel approach to cancer immunotherapy
Panel: Tumor Immunology and Cancer Immunotherapy
Revisiting the Warburg Effect: Metabolic Plasticity, Lactate Signaling, and Therapeutic Opportunities in Cancer
Panel: Polymorphisms and Metabolic Interactions in Cancer
Role of CRISPR/Cas9 Gene Editing in Targeting CXCR4, CD133 and EpCAM to Inhibit Cell Adhesion and Metastasis in Colorectal Cancer
Panel: Regenerative Medicine in Cancer Treatment Panel
Role of PDEV in Cancer Immunotherapy
Panel: Tumor Immunology and Cancer Immunotherapy
Roles of Sirtuin-1 in Lung Cancer: From Tumor Progression to Targeted Therapy
Panel: Drug Resistance and Novel Therapeutic Targets
scRNA-seq-Derived Transcriptional State Trajectories in EGFR-Mutant Lung Adenocarcinoma: A Critical Review of Therapy-Induced Convergence toward a Slow-Cycling Persister Phenotype
Panel: Single-Cell & Spatial Omics in Cancer
Selective Prevention of Immune Checkpoint Inhibitor–Induced Hypophysitis Without Compromising Antitumor Immunity
Panel: Tumor Immunology and Cancer Immunotherapy
Sialic Acid Attenuates Temozolomide-Induced Apoptosis in 1321N1 Glioma Cells via Downregulation of BAX Expression
Panel: Personalized medicine in cancer
Single-Cell and Spatial Multi-Omics in Cancer: Deciphering Tumor Heterogeneity and Advancing Precision Oncology
Panel: Single-Cell & Spatial Omics in Cancer
Spatial Metabolic Coupling as a Master Regulator of Tumor Metabolic Plasticity and Immune Checkpoint Response: A Multi-Omics Pan-Cancer Analysis
Panel: Polymorphisms and Metabolic Interactions in Cancer
Spatial Transcriptomic Signatures of ICI Resistance in Solid Tumors: Cellular Niches, Cell–Cell Interactions, and Computational Biomarkers
Panel: Bioinformatics in Cancer Panel
Splicing impact assessment of canonical splice-site LZTR1 variants of uncertain significance highlights the gap between predicted splice disruption and clinical variant interpretation
Panel: Bioinformatics in Cancer Panel
Studying the effects of Cisplatin and Artemisinin on the expression of apoptosis-related genes in mice
Panel: Personalized medicine in cancer
Systematic review of the use of Newcastle virus in cancer immunotherapy: molecular mechanisms and clinical perspectives
Panel: Personalized medicine in cancer
Targeted siRNA delivery in cervical cancer using liposomal nanoparticles
Panel: Bioinformatics in Cancer Panel
Targeting Epstein–Barr Virus-Induced Oncogenic Pathways Using Natural Polyphenols: Therapeutic Potential of EGCG and Resveratrol
Panel: Carcinogenic Viruses
Targeting Metabolic Vulnerabilities in Cancer: From the Warburg Effect to Antiparasitic Drug Repurposing
Panel: Polymorphisms and Metabolic Interactions in Cancer
Targeting the SLC7A11/GSH/GPX4 Axis in Cancer: From Redox Homeostasis to Therapeutic Vulnerability
Panel: Regenerative Medicine in Cancer Treatment Panel
The Association Between the Gut Microbiome and Cancer Treatment: From Modulation of Therapeutic Response to Microbial Interventions
Panel: The role of the microbiome in cancer
The Gut Microbiome as a Predictor of Immune Checkpoint Inhibitor Efficacy and Immune-Related Toxicity: A Translational Evidence Gap Analysis
Panel: The role of the microbiome in cancer
The Intratumoral Microbiome in Cancer: Molecular Mechanisms and Therapeutic Perspectives
Panel: The role of the microbiome in cancer
The Mitochondrial Transfer Paradox: A Comparative Transcriptomic and Connectivity Map Profiling of Divergent Fates in Tumor and Immune Cells
Panel: Bioinformatics in Cancer Panel
The Nurse's Role in Translating Genomic Findings into Person-Centered Palliative Care Plans for Cancer Patients: A Scoping Review
Panel: Regenerative Medicine in Cancer Treatment Panel
The Role of Artificial Intelligence in Tumor Surgery: A Systematic Review of Clinical Applications, Diagnostic Accuracy, and Postoperative Outcomes
Panel: Personalized medicine in cancer
The Role of Covert Germline Predisposition and Polygenic Susceptibility in Pediatric Acute Lymphoblastic Leukemia and Their Clinical Implications
Panel: Bioinformatics in Cancer Panel
The Role of Gut Microbiome in Cancer: From Dysbiosis to Non‑Invasive Biomarkers
Panel: Polymorphisms and Metabolic Interactions in Cancer
The Role of the Gut Microbiome and Microbial Metabolites in Modulating Responses to Immune Checkpoint Inhibitors (ICIs): A Review of Immunological Mechanisms, Clinical Evidence and Microbiome-Based Therapeutic Strategies
Panel: The role of the microbiome in cancer
The Role of the Microbiome in Cancer: From Carcinogenesis to Therapeutic Response
Panel: Regenerative Medicine in Cancer Treatment Panel
The stress-microbiome-cancer triad and the impact of catecholamines on Host-Microbe Interactions and tumor progression
Panel: The role of the microbiome in cancer
TLR3 Genetic Variation in Virus-Related Hepatocellular Carcinoma
Panel: Polymorphisms and Metabolic Interactions in Cancer
Transcriptome-Derived Immune Activity in Breast Cancer Reveals Prognostic CCL19–IL10 Expression States with External Evaluation in SCAN-B
Panel: Tumor Immunology and Cancer Immunotherapy
Transcriptome-Driven Repurposing of Approved Drugs for Cervical Cancer: A Connectivity Map Approach
Panel: Multi-omics and Systems Oncology
Transcriptome-Driven Repurposing of Approved Drugs for Pancreatic Ductal Adenocarcinoma: A Connectivity Map Approach
Panel: Multi-omics and Systems Oncology
Transcriptomic and PPI Network Analysis Reveals Hub Genes in Breast Cancer-Associated Fibroblasts
Panel: Bioinformatics in Cancer Panel
Transcriptomic Dissection of Pediatric Brain Tumors: Unraveling the Glial-Stem vs. Neuronal Dichotomy in Ependymoma and Medulloblastoma
Panel: Bioinformatics in Cancer
Tumor-Suppressor Checkpoints in Partial Reprogramming: Balancing Epigenetic Rejuvenation, Lineage Fidelity, and Oncogenic Risk
Panel: Epigenetics and Cancer Panel
Unraveling the Cellular and Spatial Heterogeneity of Ocular Cancers through Single-Cell and Spatial Omics
Panel: Single-Cell & Spatial Omics in Cancer
When Bacterial Redox Meets Tumor Metabolism: Decoding the Enterococcus faecalis–Cancer Crosstalk
Panel: Regenerative Medicine in Cancer Treatment Panel
